Daxin Peng Selected Research

Daxin Peng Research Topics

Disease

40	Influenza in Birds (Avian Flu) 12/2022 - 06/2002
16	Infections 01/2022 - 07/2005
7	Human Influenza (Influenza) 01/2022 - 11/2010
4	Virus Diseases (Viral Diseases) 01/2021 - 08/2015
3	Bacterial Infections (Bacterial Infection) 12/2021 - 07/2005
2	Inflammation (Inflammations) 07/2020 - 11/2017
1	Communicable Diseases (Infectious Diseases) 10/2020
1	Rheumatoid Arthritis 01/2020
1	Body Weight (Weight, Body) 01/2020
1	Acute Lung Injury 04/2017
1	Acute-Phase Reaction 04/2017
1	Lung Injury 04/2017
1	Brucellosis (Malta Fever) 09/2014
1	Shock 07/2014
1	Respiratory Tract Infections (Respiratory Tract Infection) 06/2011
1	Otitis Media 06/2011

Drug/Important Bio-Agent (IBA)

19	VaccinesIBA 12/2022 - 11/2010
15	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2012
12	Hemagglutinins (Hemagglutinin)IBA 01/2022 - 06/2002
9	Biological ProductsIBA 03/2022 - 12/2009
7	Neuraminidase (Sialidase)IBA 10/2021 - 10/2008
3	Inactivated VaccinesIBA 11/2021 - 01/2019
3	EpitopesIBA 10/2021 - 03/2013
3	Amino Acids FDA Link 01/2020 - 06/2002
2	Peptides (Polypeptides)IBA 12/2022 - 10/2021
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 10/2021
2	Tigecycline (Tygacil)FDA Link 12/2021 - 10/2021
2	Antiviral Agents (Antivirals)IBA 09/2020 - 01/2020
2	Attenuated VaccinesIBA 01/2020 - 01/2017
2	Virulence Factors (Pathogenicity Factors)IBA 11/2005 - 07/2005
1	OccludinIBA 01/2022
1	Colistin (Coly-Mycin)FDA Link 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2022
1	Long Noncoding RNAIBA 12/2021
1	RNA (Ribonucleic Acid)IBA 12/2021
1	Carbapenems (Carbapenem Antibiotics)IBA 12/2021
1	Riboflavin (Vitamin B2)FDA LinkGeneric 11/2021
1	Marker VaccinesIBA 10/2021
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 03/2021
1	CytokinesIBA 12/2020
1	Suppressor of Cytokine Signaling 1 ProteinIBA 12/2020
1	Methionine (L-Methionine)FDA Link 11/2020
1	DNA (Deoxyribonucleic Acid)IBA 10/2020
1	ferric oxide (iron oxide)IBA 09/2020
1	ChitosanIBA 09/2020
1	Immunoglobulin A (IgA)IBA 09/2020
1	Inositol (Myoinositol)IBA 07/2020
1	EnzymesIBA 07/2020
1	teriflunomideIBA 01/2020
1	Janus KinasesIBA 01/2020
1	Janus Kinase InhibitorsIBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	Leflunomide (Arava)FDA LinkGeneric 01/2020
1	SuspensionsIBA 03/2019
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 01/2019
1	LipidsIBA 01/2019
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2018
1	NF-kappa B (NF-kB)IBA 11/2017
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 10/2017
1	Complement System Proteins (Complement)IBA 04/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2017
1	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2017
1	sialic acid receptorIBA 01/2017
1	Type III Secretion SystemsIBA 01/2016
1	EmulsionsIBA 01/2016
1	Immunologic Adjuvants (Immunologic Adjuvant)IBA 01/2016
1	AntigensIBA 08/2015
1	LigandsIBA 08/2015
1	FlagellinIBA 08/2015
1	Subunit VaccinesIBA 08/2015
1	AcidsIBA 07/2014
1	Glycoproteins (Glycoprotein)IBA 01/2014
1	Interleukin-6 (Interleukin 6)IBA 09/2012
1	Immunoglobulins (Immunoglobulin)IBA 12/2011
1	Immunoglobulin G (IgG)IBA 11/2010
1	MF59 oil emulsionIBA 11/2010
1	Secretory Immunoglobulin A (SIgA)IBA 11/2010
1	OligosaccharidesIBA 07/2005
1	Basic Amino Acids (Basic Amino Acid)IBA 06/2002

Therapy/Procedure

1	Intranasal Administration 11/2010